Enorama Pharma

0.32 SEK

-12.97 %

Less than 1K followers

ERMA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-12.97 %
+3.87 %
-56.84 %
-83.14 %
-88.50 %
-88.42 %
-89.42 %
-98.29 %
-94.94 %

Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are sold mainly through retailers who sell the product under their own brand. The largest market is found in the Nordic region, but with a share of sales exported globally. Enorama Pharma was founded in 2006 and the headquarters are located in Malmö.

Read more
Market cap
24.02M SEK
Turnover
9.72K SEK
Revenue
2.74M
EBIT %
-2,293.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19/8
2026

Interim report Q2'26

18/11
2026

Interim report Q3'26

17/2
2027

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.